References
- Defazio G, Berardelli A, Fabbrini G, et al. Pain as a nonmotor symptom of Parkinson disease: evidence from a case-control study. Arch Neurol. 2008;65(9):1191–1194.
- Geroin C, Gandolfi M, Bruno V, et al. Integrated approach for pain management in Parkinson disease. Curr Neurol Neurosci Rep. 2016;16(4):28.
- Perez-Lloret S. Clinical trials in Parkinson's disease. Cham: Springer; 2020.
- Buhmann C, Wrobel N, Grashorn W, et al. Pain in Parkinson disease: a cross-sectional survey of its prevalence, specifics, and therapy. J Neurol. 2017;264(4):758–769.
- Chaudhuri KR, Rizos A, Trenkwalder C, et al. King's Parkinson's disease Pain Scale, the first scale for pain in PD: an international validation. Mov Disord. 2015;30(12):1623–1631.
- Barrett B, Brown D, Mundt M, et al. Sufficiently important difference: expanding the framework of clinical significance. Med Decis Making. 2005;25(3):250–261.
- Crosby RD, Kolotkin RL, Williams GR. Defining clinically meaningful change in health-related quality of life. J Clin Epidemiol. 2003;56(5):395–407.
- Lin K-c, Fu T, Wu C-y, et al. Minimal detectable change and clinically important difference of the stroke impact scale in stroke patients. Neurorehabil Neural Repair. 2010;24(5):486–492.
- Shulman LM, Gruber-Baldini AL, Anderson KE, et al. The clinically important difference on the unified Parkinson's disease rating scale. Arch Neurol. 2010;67(1):64–70.
- Gibb W, Lees A. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry. 1988;51(6):745–752.
- Taghizadeh G, Joghataei MT, Goudarzi S, et al. King's Parkinson's disease pain scale cut-off points for detection of pain severity levels: a reliability and validity study. Neurosci Lett. 2021;745:135620.
- Reuter I, Mehnert S, Leone P, et al. Effects of a flexibility and relaxation programme, walking, and Nordic walking on Parkinson's disease. J Aging Res. 2011;2011:232473.
- Allen NE, Moloney N, van Vliet V, et al. The rationale for exercise in the management of pain in Parkinson's disease. J Parkinsons Dis. 2015;5(2):229–239.
- Capato TTC, de Vries NM, IntHout J, et al. Multimodal balance training supported by rhythmic auditory stimuli in Parkinson disease: effects in freezers and nonfreezers. Phys Ther. 2020;100(11):2023–2034.
- Kluger BM, Garimella S, Garvan C. Minimal clinically important difference of the modified fatigue impact scale in Parkinson's disease. Parkinsonism Relat Disord. 2017;43:101–104.
- Chan A, Yo TE, Wang XJ, et al. Minimal clinically important difference of the Multidimensional Fatigue Symptom Inventory-Short Form (MFSI-SF) for fatigue worsening in Asian breast cancer patients. J Pain Symptom Manage. 2018;55(3):992–997. e2.
- Wang H, Wang B, Zhang X, et al. Relations among sensitivity, specificity and predictive values of medical tests based on biomarkers. Gen Psych. 2021;34(2):e100453.
- Roach VJ, Fung H, Cockram CS, et al. Evaluation of glucose intolerance in pregnancy using biochemical markers of fetal hyperinsulinemia. Gynecol Obstet Invest. 1998;45(3):174–176.